Reply to Letter to the Editor: Short-Term Outcomes of Aflibercept Therapy for Diabetic Macular Edema in Patients With Incomplete Response to Ranibizumab and/or Bevacizumab

被引：0
|
作者：
Moshfeghi, Darius M. [1 ]
机构：
[1] Stanford Univ, Sch Med, Byers Eye Inst, Stanford, CA 94305 USA
来源：
OPHTHALMIC SURGERY LASERS & IMAGING RETINA | 2017年 / 48卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：281 / 281
页数：1
相关论文
共 50 条
  • [1] Letter to the Editor: Short-Term Outcomes of Aflibercept Therapy for Diabetic Macular Edema in Patients With Incomplete Response to Ranibizumab and/or Bevacizumab
    Calugaru, Dan
    Calugaru, Mihai
    OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2017, 48 (04): : 280 - 280
  • [2] Short-Term Outcomes of Aflibercept Therapy for Diabetic Macular Edema in Patients With Incomplete Response to Ranibizumab and/or Bevacizumab
    Wood, Edward H.
    Karth, Peter A.
    Moshfeghi, Darius M.
    Leng, Theodore
    OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2015, 46 (09): : 950 - 954
  • [3] Short-term outcomes of aflibercept therapy for diabetic macular edema in patients with incomplete response to ranibizumab and/or bevacizumab
    Ores, Raphaelle
    Philippakis, Elise
    Massin, Pascale G.
    Tadayoni, Ramin
    Dupas, Benedicte Marie
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [4] Short-Term Outcomes of Switching to Ranibizumab Therapy for Diabetic Macular Edema in Patients with Persistent Fluid After Bevacizumab Therapy
    Lee, Jae Hyung
    Lee, Won Ki
    Kim, Sung Eun
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2016, 32 (10) : 659 - 664
  • [5] Aflibercept therapy for diabetic macular edema resistant to ranibizumab and bevacizumab
    Karth, Peter
    Moshfeghi, Darius M.
    Leng, Theodore
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [6] Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
    Wells, John A.
    Glassman, Adam R.
    Ayala, Allison R.
    Jampol, Lee M.
    Aiello, Lloyd Paul
    Antoszyk, Andrew N.
    Arnold-Bush, Bambi
    Baker, Carl W.
    Bressler, Neil M.
    Browning, David J.
    Elman, Michael J.
    Ferris, Frederick L.
    Friedman, Scott M.
    Melia, Michele
    Pieramici, Dante J.
    Sun, Jennifer K.
    Beck, Roy W.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (13): : 1193 - 1203
  • [7] Short-Term Effects of Early Switching to Ranibizumab or Aflibercept in Diabetic Macular Edema Cases With Non-Response to Bevacizumab
    Ashraf, Mohammed
    Souka, Ahmed A. R.
    ElKayal, Hassan
    OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2017, 48 (03): : 230 - 236
  • [8] Reply to the letter to the editor: Aflibercept in diabetic macular edema refractory to previous bevacizumab: outcomes and predictors of success
    Rita Laiginhas
    Marta Inês Silva
    Manuel Sousa Falcão
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2018, 256 : 1355 - 1356
  • [9] Reply to the letter to the editor: Aflibercept in diabetic macular edema refractory to previous bevacizumab: outcomes and predictors of success
    Laiginhas, Rita
    Silva, Marta Ines
    Falcao, Manuel Sousa
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2018, 256 (07) : 1355 - 1356
  • [10] Reply to Letter to the Editor: Aflibercept For Diabetic Macular Edema in Eyes Previously Treated With Ranibizumab And/Or Bevacizumab May Further Improve Macular Thickness
    Shah, Chirag P.
    Heier, Jeffrey S.
    OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2017, 48 (07): : 529 - 529
12345